Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	54.53	142.82	144.42	104.79	52.86
Short-Term Investments	46.62	-	29.88	-	-
Cash & Short-Term Investments	101.15	142.82	174.3	104.79	52.86
Cash Growth	-29.18%	-18.06%	66.33%	98.25%	16.52%
Other Receivables	-	-	3.24	0.03	-
Receivables	-	-	3.24	125.03	25
Prepaid Expenses	0.71	0.52	0.87	0.53	0.41
Other Current Assets	2.21	4.46	2.61	2.4	4.79
Total Current Assets	104.07	147.81	181.02	232.75	83.06
Property, Plant & Equipment	0.27	0.52	0.27	0.38	0.29
Long-Term Deferred Charges	0.27	-	-	-	-
Total Assets	104.61	148.33	181.29	233.14	83.35
Accounts Payable	0.18	1.34	0.13	1.02	0.38
Accrued Expenses	12.12	5.54	14.07	10.52	5.63
Current Portion of Long-Term Debt	0.03	15.15	0.91	-	3.66
Current Portion of Leases	0.27	0.24	0.25	0.23	0.23
Current Unearned Revenue	6	-	-	-	-
Other Current Liabilities	-	-	-	-	2.5
Total Current Liabilities	18.6	22.26	15.36	11.77	12.41
Long-Term Debt	15	-	14.92	15.5	11.43
Long-Term Leases	-	0.27	-	0.13	-
Long-Term Unearned Revenue	-	6	-	-	-
Total Liabilities	33.6	28.53	30.28	27.4	23.84
Common Stock	0.06	0.06	0.06	0.06	0.04
Additional Paid-In Capital	521.02	513.99	507.77	500.37	296.39
Retained Earnings	-450.11	-394.26	-356.72	-294.69	-236.92
Comprehensive Income & Other	0.04	-	-0.1	-	-
Shareholders' Equity	71	119.8	151.01	205.74	59.51
Total Liabilities & Equity	104.61	148.33	181.29	233.14	83.35
Total Debt	15.3	15.66	16.08	15.86	15.33
Net Cash (Debt)	85.85	127.17	158.22	88.93	37.53
Net Cash Growth	-32.49%	-19.63%	77.91%	136.96%	22.61%
Net Cash Per Share	1.44	2.16	2.71	1.65	1.10
Filing Date Shares Outstanding	59.71	58.9	58.58	58.1	47.25
Total Common Shares Outstanding	59.65	59.2	58.56	58.08	38.67
Working Capital	85.47	125.55	165.66	220.98	70.65
Book Value Per Share	1.19	2.02	2.58	3.54	1.54
Tangible Book Value	71	119.8	151.01	205.74	59.51
Tangible Book Value Per Share	1.19	2.02	2.58	3.54	1.54

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q